Tag: Preclinical Research

March 28, 2018

GCAC to Participate in Medical Cannabis Study Conducted by University of British Columbia Professor, Dr. Alasdair Barr

Global Cannabis Applications Corp. (GCAC) (CSE:APP, FRA:2FA, OTCQB:FUAPF), a leading developer of innovative data technologies for the cannabis industry, is...
February 5, 2018

PolarityTE™ Provides Business Updates on Clinical Use of SkinTE: Regeneration of Full-Thickness Skin

PolarityTE (NASDAQ:COOL), today announced that initial results from the clinical applications of the commercially launched SkinTE are yielding outcomes that...
January 19, 2018

PCI Biotech: Extension of preclinical research collaboration agreement with a top-10 large pharma company

PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that they are extending the preclinical research collaboration with...
December 26, 2017

DelMar Pharmaceuticals Announces Fast Track Designation for VAL-083 in Recurrent Glioblastoma

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development and commercialization of new...
November 21, 2017

DelMar Presents Positive Interim Results from VAL-083 Study in MGMT-unmethylated Recurrent GBM at The Society for NeuroOncology Annual Meeting

DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new cancer therapies, today provided...
September 29, 2017

DelMar Pharmaceuticals Announces Fiscal Year 2017 Financial Results

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, announced its financial results...
September 12, 2017

Theralase Compares Efficacy of Its Cancer Drugs

Theralase Technologies announced it demonstrated increased efficacy from their anti-cancer drug TLD-1633 compared to its lead anti-cancer drug TLD-1433.